From a rare marine sea squirt found only in the waters around the Spanish island of Ibiza comes a potential COVID-19 treatment called Aplidin that researchers say has proven 27.5 times more effective than the well-known remdesivir in human cells in the lab.
The finding, reported Monday by an international team in the journal Science, comes at a time when potential treatments have been overshadowed by the U.S. vaccination campaign, now trying to recover from a slower-than-expected start.

Aplidin, already approved in Australia for treating multiple myeloma, has been developed as a potential COVID-19 treatment by the Spanish drug company PharMar.

Aplidin, already approved in Australia for treating multiple myeloma, has been developed as a potential COVID-19 treatment by the Spanish drug company PharMar.

[link to eu.jsonline.com (secure)]